Yumanity Therapeutics Inc. Soared
Fri, Jun 03, 2022 at 05:30 PM
Yumanity Therapeutics Inc. (YMTX:NASDAQ) jumped higher at $1.42, representing a gain of 34%. On Thu, Jun 02, 2022, YMTX:NASDAQ touched a New 2-Week Intraday High of $1.56. The stock got featured on our News Catalysts scanner on Thu, May 12, 2022 at 04:52 PM in the 'INVESTOR UPDATE' category. From Fri, May 20, 2022, the stock recorded 62.50% Up Days and 33.33% Green Days
The stock spiked on Thu, Jun 02, 2022 at $1.56 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Yumanity Therapeutics Inc. (YMTX:NASDAQ)
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases.
Top 10 Gainers:
- Turning Point Therapeutics, Inc. (TPTX:NASDAQ), 118.35%
- Energy Focus, Inc. (EFOI:NASDAQ), 48.65%
- Galecto Inc. (GLTO:NASDAQ), 35.17%
- Yumanity Therapeutics Inc. (YMTX:NASDAQ), 33.96%
- Houston American Energy Corp. (HUSA:NYSEMKT), 27.54%
- Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ), 26.41%
- Forian Inc. (FORA:NASDAQ), 24.23%
- Integrated Media Technology Limited (IMTE:NASDAQ), 22.88%
- Eros STX Global Corporation A (ESGC:NYSE), 22.18%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 21.21%